BioSpace News Archive

Ambu is a rapidly growing medical device maker and pioneer of sterile, single-use endoscopes.

Y-mAbs Therapeutics, Inc. announced that it has entered into an agreement with Memorial Sloan Kettering Cancer Center and Massachusetts Institute of Technology for a worldwide exclusive license and research collaboration to develop and commercialize antibody constructs based on the SADA-BiDE Pre-targeted Radioimmunotherapy Platform, a concept also referred to as Liquid RadiationTM.

Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today asserted three recently issued oncology patents against ArcherDX in its ongoing patent infringement action filed in the U.S. District Court of Delaware.

As part of its mission to make positive impacts in the city it’s called home for 90 years, Battelle announced it is donating a total of $1 million to three central Ohio organizations to provide increased emergency support because of the coronavirus pandemic. “It is well known that, in normal time

The successful collaboration between Fudan University, its affiliated Public Health Clinical Center and Active Motif has reached a new milestone.

ArcherDX, Inc., today announced that new data from its research collaboration with UCL and the Francis Crick Institute as part of the Cancer Research UK-funded UCL-sponsored TRACERx study was chosen to be presented by UCL on Tuesday, April 28 at 2:15 p.m. ET during the 2020 American Association for Cancer Research (AACR) Virtual Annual Meeting.

The Blood Connection, has received its first convalescent plasma donation in South Carolina.

The NORD COVID-19 Critical Relief Program provides support to rare disease patients and families facing financial challenges, helping them afford essential non-medical expenses.

Southern California company Direct Components, Inc. releases SAM SEAL™ to aide health workers [15-April-2020] LAGUNA BEACH, Calif. , April 15, 2020 /PRNewswire/ -- Direct Components, Inc. has released a groundbreaking PPE (personal protective equipment) enhancement, SAM SEAL™, that reduces the probability of COVID-19 (corona virus) contamination via application of a f

Babson Diagnostics (Babson), a transformative diagnostic blood testing company, announced today it will launch a COVID-19 serology testing service. COVID-19 serology testing is used to detect the presence of antibodies to SARS-CoV-2 in the bloodstream, which makes it the preferred method for evaluating whether a person has had a SARS-CoV-2 infection in the past and whether they may have developed immunity to SARS-CoV-2